Karen Gheesling Mullis, Ph.D.
Login to view DISC.With over 30 years in pharmaceutical R&D, Karen Gheesling Mullis now serves as the Director of New Ventures at Washington University. She leverages extensive experience from Pfizer and venture capital to guide the commercialization of university intellectual property, helping researchers launch and scale new biotech startups. She holds a Ph. D. in Biochemistry and a PMP certification.
Karen is passionate about fostering the next generation of innovators and entrepreneurs within the academic community. She is a board member for Equalize, an organization dedicated to addressing the disparity of women academic inventors forming university startups, reflecting a deep commitment to mentorship and creating opportunities for underrepresented founders.
She led the clinical development and registration for several breakthrough oncology drugs at Pfizer, including IBRANCE™ and XALKORI.
Read the full overview →How Karen shows up
Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Topics Karen cares about
Work history
Media appearances
DISC profile (public)
DISC behavioral profile
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Other Washington University in St. Louis Employees
Explore more public profiles from related professionals.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.